» Articles » PMID: 9600227

Protein Nitration in Parkinson's Disease

Overview
Specialties Neurology
Pathology
Date 1998 May 26
PMID 9600227
Citations 140
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress has been proposed as a pathogenetic mechanism in Parkinson's disease (PD). One mechanism of oxidative cellular injury is the nitration of protein tyrosine residues, mediated by peroxynitrite, a reaction product of nitric oxide and superoxide radicals. We demonstrate here the presence of nitrotyrosine immunoreactivity in Lewy bodies within melanized neurons and in amorphous deposits associated with intact and degenerating neurons. The core of the Lewy body was frequently intensely immunolabeled, while the rim was lightly labeled or unlabeled. This likely reflects the fact that tyrosine residues of neurofilament proteins are primarily localized to Lewy body cores, and suggests that nitrotyrosine is present in neurofilament protein itself. Although these observations are as yet unable to provide a definitive link between oxidative stress and neuronal dysfunction, they demonstrate that oxidative stress has occurred within the vulnerable neurons of PD, leaving a permanent marker of oxidative modification of neuronal proteins within the target cells of neurodegeneration. In addition, these observations provide a potential link between excitotoxicity and oxidative stress within the vulnerable neurons of PD and represent a pathogenetic mechanism in common with the 2 other major age-related neurodegenerative diseases, Alzheimer disease and amyotrophic lateral sclerosis.

Citing Articles

In vitro immuno-prevention of nitration/dysfunction of myogenic stem cell activator HGF, towards developing a strategy for age-related muscle atrophy.

Tanaka S, Elgaabari A, Seki M, Kuwakado S, Zushi K, Miyamoto J Aging Cell. 2024; 23(10):e14337.

PMID: 39297318 PMC: 11464115. DOI: 10.1111/acel.14337.


Positron Emission Tomography with [F]ROStrace Reveals Progressive Elevations in Oxidative Stress in a Mouse Model of Alpha-Synucleinopathy.

Gallagher E, Hou C, Zhu Y, Hsieh C, Lee H, Li S Int J Mol Sci. 2024; 25(9).

PMID: 38732162 PMC: 11084161. DOI: 10.3390/ijms25094943.


LRRK2; Communicative Role in the Treatment of Parkinson's Disease and Ulcerative Colitis Overlapping.

Lashgari N, Roudsari N, Niknejad A, Shamsnia H, Shayan M, Mohaghegh Shalmani L CNS Neurol Disord Drug Targets. 2024; 23(10):1177-1188.

PMID: 38279762 DOI: 10.2174/0118715273270874231205050727.


Age-related nitration/dysfunction of myogenic stem cell activator HGF.

Elgaabari A, Imatomi N, Kido H, Nakashima T, Okuda S, Manabe Y Aging Cell. 2023; 23(2):e14041.

PMID: 37985931 PMC: 10861216. DOI: 10.1111/acel.14041.


Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse model.

Fang T, Sun Y, Pearce A, Eleuteri S, Kemp M, Luckhurst C Nat Commun. 2023; 14(1):7295.

PMID: 37957154 PMC: 10643470. DOI: 10.1038/s41467-023-42876-1.